GlassScriptPhysician profile
Narat Srivali
NPI 1679867873
$1,541.28
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,530 · 2020: $11.56.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Veran Medical Technologies, INC. | $696.57 | 2019 | |
| Glaxosmithkline, LLC. | $146.50 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.60 | 2019 | |
| Grifols USA, LLC | $91.13 | 2019 | |
| Mylan Specialty L.P. | $65.08 | 2019 | |
| Medtronic USA, INC. | $59.72 | 2019 | |
| Mallinckrodt Enterprises LLC | $55.35 | 2019 | |
| Genzyme Corporation | $45.30 | 2019 | |
| Electromed, INC. | $39.32 | 2019 | |
| Shire North American Group INC | $37.06 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $32.54 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $25.02 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.99 | 2019 | |
| Genentech USA, INC. | $21.41 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $19.40 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $18.92 | 2019 | |
| Resmed Corp | $16.82 | 2019 | |
| Circassia INC. | $14.06 | 2019 | |
| Advanced Respiratory, INC | $12.58 | 2019 | |
| Merck Sharp & Dohme LLC | $10.91 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Narat Srivali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.